Hyperlipidemia promotes the chronic inflammatory disease atherosclerosis through poorly understood mechanisms. Atherogenic lipoproteins activate platelets, but it is unknown whether platelets contribute to early inflammatory atherosclerotic lesions. To address the role of platelet aggregation in diet-induced vascular disease, we studied ␤3 integrin-deficient mice (lacking platelet integrin ␣IIb␤3 and the widely expressed nonplatelet integrin ␣v␤3) in two models of atherosclerosis, apolipoprotein E (apoE)-null and low-density lipoprotein receptor (LDLR)-null mice. Unexpectedly, a high-fat, Western-type (but not a low-fat) diet caused death in two-thirds of the ␤3 ؊/؊ apoE ؊/؊ and half of the ␤3 ؊/؊ LDLR ؊/؊ mice due to noninfectious pneumonitis. In animals from both models surviving high-fat feeding, pneumonitis was absent, but aortic atherosclerosis was 2-to 6-fold greater in ␤3 ؊/؊ compared with ␤ ؉/؉ littermates. Expression of CD36, CD40L, and CD40 was increased in lungs of ␤3 ؊/؊ LDLR ؊/؊ mice. Each was also increased in smooth muscle cells cultured from ␤3-deficient mice and suppressed by retroviral reconstitution of ␤3. These data show that the platelet defect caused by ␣IIb␤3 deficiency does not impair atherosclerotic lesion initiation. They also suggest that ␣v␤3 has a suppressive effect on inflammation, the loss of which induces atherogenic mediators that are amplified by diet-induced hyperlipidemia.
A therosclerosis is the most common cause of death in developed countries. People with established vascular disease benefit from pharmacologic therapies directed at lipids, blood pressure, and clots, and interventions that restore blood flow to diseased arteries. These treatments are of no use to the large number of people whose first hint of coronary artery disease is sudden death, caused by thrombus formation at the site of a ruptured atherosclerotic plaque that was too small to cause symptoms (1) . Plaques destined to cause clinical events probably result from months to years of chronic inflammation. Exactly how this process starts and evolves is unclear.
Inflammation is affected by hyperlipidemia, a robust risk factor for atherosclerosis (2) . Atherogenic lipoproteins up-regulate adhesion molecules, induce the production of cytokines, elicit immune reactions against oxidized epitopes, and activate platelets. Inhibition of platelet function decreases clinical events in patients with complex atherosclerotic lesions (3) . Platelets are also postulated to participate in the early stages of atherogenesis, but data addressing this notion are contradictory. In rabbits with diet-induced hyperlipidemia, platelets are recruited to lesion-prone sites before lesions develop (4) . Mice with deficiency of von Willebrand factor, critical for platelet adhesion under high-flow conditions, have less atherosclerosis at discrete sites after eating a toxic diet (5) . However, studies in von Willebrand-deficient pigs (6, 7) and humans (8, 9) provide conflicting data about the role of platelet adhesion in plaque formation. In humans, the antiplatelet and antiinflammatory drug aspirin is effective for the primary prevention of coronary disease in some groups but not others (10) . Humans with Glanzmann thrombasthenia, a disorder of platelet aggregation caused by mutations in the ␣IIb␤3 integrin, do not seem to be protected from vascular disease (11) .
Integrins are cell-surface heterodimers that mediate interactions between the extracellular environment and platelets, inflammatory cells, and the vasculature. The ␤3 integrin subfamily consists of two integrins, ␣IIb␤3 and ␣v␤3. ␣IIb␤3 (glycoprotein IIb͞IIIa) is expressed on platelets and megakaryocytes and participates in thrombus formation. It is a target of inhibitors known to provide clinical benefit to patients with acute coronary syndromes undergoing percutaneous interventions (12) . ␣v␤3 is a nonplatelet integrin expressed in blood vessels and some inflammatory cells (13) . Human atherosclerotic lesions show extensive expression of ␣v␤3, predominantly in smooth muscle cells and endothelial cells, and vascular injury up-regulates ␣v␤3 on smooth muscle cells (14, 15) . The ␤3 integrins could modulate atherosclerosis through plateletdependent or vascular wall-dependent mechanisms, but the exact role of ␤3 in vascular disease is unclear.
To determine whether the ␤3 molecule is involved in dietinduced atherosclerosis, we studied ␤3 mice. Given the platelet defect in ␤3-null mice and the widespread use of antiplatelet agents to prevent atherosclerosis, we expected to find less vascular disease in ␤3 Ϫ/Ϫ mice. Surprisingly, ␤3-null animals had more atherosclerosis and a high frequency of fatal pneumonitis, suggesting that the ␤3 integrin has a tonic suppressive effect on diet-induced inflammatory events at sites as diverse as the vascular wall and the lung.
Materials and Methods
Animals. ␤3-deficient mice of mixed genetic background (C57BL͞6 and 129Sv) were bred with apoE-null mice in the C57BL͞6 background or LDLR-null mice in the C57BL͞6 background to generate ␤3
littermates that were used for experiments. Animals were genotyped at the ␤3 locus (16) by using a forward wild-type primer (5Ј-CTTAGACACCTGCTACGGGC), a reverse neo-specific primer (5Ј-CACGAGACTAGTGAGACGTG), and a reverse wild-type primer (5Ј-CCTGCCTGAGGCTGAGTG). Mice housed in a specific pathogen-free barrier facility were weaned at the age of 3 weeks to standard mouse chow providing 6% calories as fat. At the age of 6 weeks, sex-matched animals were started on a Western-type diet containing 0.15% cholesterol providing 42% calories as fat (TD 88137, Harlan, Madison, WI).
Cages were monitored daily. Dead mice were necropsied either immediately or after storage overnight at 4°C by the same experienced veterinarian (M.L.). In the apoE model, 18 spon-taneous deaths were recorded for ␤3-null mice. Eight showed pulmonary inflammation. Ten could not be evaluated because of postmortem changes. Necropsies showed fatty liver in some mice, but heart, kidneys, intestinal tract, brain, and spleen were normal. To determine whether pulmonary inflammation was present in mice surviving the Western-type diet, lungs were perfused and formalin-fixed from male and female mice of both ␤3 genotypes in the apoE-and LDLR-null models at the time of isolation of aortas for atherosclerosis assays.
Analytical Procedures. Cholesterol, triglycerides, and glucose were measured in serum from mice after a 4-h fast as described (17) . Lipoproteins were analyzed by fast protein liquid chromatography with pooled serum samples (18) .
Intimal Lesion Quantification. Atherosclerosis was measured by the en face technique (19) . Pinned aortas were imaged with a digital camera and analyzed by using an image-processing program. The percentage of involvement of the intimal surface area is reported for the arch (encompassing the surface from the aortic valve to the left subclavian artery), the thoracic aorta (extending to the final intercostal artery), and the abdominal aorta (to the ileal bifurcation).
Preparation of Retrovirus and Infection of Smooth Muscle Cells.
Human ␤3 integrin in the ⌬U3 retroviral vector (⌬U3-h␤3; ref. 20) and a LacZ control vector (⌬U3nlsLZ) were transfected into separate aliquots of 293GPG packaging cells cultured in DMEM with 10% heat-inactivated FBS supplemented with tetracycline, puromycin, and G418 as described (20) . Viruses were collected at regular intervals for up to 96 h after transfection.
Smooth muscle cells were cultured from the aortas of ␤3
mice by the explant technique. Vessels were cleaned of adventitia, washed in medium, and chopped into Ϸ1-mm cubes that were suspended in a small volume of medium and transferred to a T25 flask. Explants were dispersed onto the culture surface, and then the flask was tilted slowly, cap-side-up, with the tissue fragments attached to the vertical culture surface. Fresh medium was placed in the bottom of the flask, and then 2 h later the flask was returned to the usual culture position, allowing the fresh medium to cover the adherent aortic tissue. Smooth muscle cells growing from the explants were passaged, expanded, and verified to be smooth muscle cells by staining with a smooth muscle ␣-actin antibody. These cells were transduced with ⌬U3-h␤3 or ⌬U3nlsLZ for 24 h in the presence of medium containing polybrene (8 g͞ml, Sigma). Cells then were incubated for an additional 48 h in DMEM with 10% heat-inactivated FBS before harvesting.
Quantitative RT-PCR-Based Gene Expression. Total RNA prepared from lungs, cultured smooth muscle cells, or liver was used to prepare complementary DNA and subjected to quantitative PCR in a GeneAmp 5700 sequence detector (Applied Biosystems) as described (18) . Aliquots of RNA not subjected to reverse transcription were included in each assay as negative controls. The primer pairs used were 5Ј-CAAGCTCCTTGGCATGGTAGA and 5Ј-TGGATTTGCAAGCACAATATGAA (CD36), 5Ј-GAACTTG-GAGGTCCTACAGAAAGG and 5Ј-TGCCCATCACGACAG-GAAT (CD40), 5Ј-AGCCAACCTTCCCCCAGAT and 5Ј-CACAGCAAAAAGCACAGATCCA (CD40L), 5Ј-CACC-CCTTGAACCTCACTAAACA and 5Ј-AAAGGACATCGC-AAAGATGACA [ATP binding cassette A1 (ABCA1)], and 5Ј-CGCTCCTGGAAGATGGTGAT and 5Ј-GGCAAATTCA-ACGGCACAGT (GAPDH). Results were normalized to GAPDH mRNA in each sample, which was unaffected by genotype.
Western Blotting. Proteins were extracted from lungs and cultured smooth muscle cells and subjected to SDS͞PAGE in gradient gels under denaturing conditions. Protein signals on blots were detected by chemiluminescence. For CD36, the primary antibody was a rabbit polyclonal antibody (SC-9154, Santa Cruz Biotechnology) used at a dilution of 1:200, and the secondary antibody was donkey anti-rabbit (NA 934V, Amersham Biosciences) used at 1:5,000. For human ␤3, the primary antibody was mouse monoclonal antibody 7G2 used at 1:3,000. For the 70-kDa heat-shock cognate protein (HSC70), the primary antibody was a mouse monoclonal antibody from Santa Cruz Biotechnology (SC-7298) used at 1:1,000. For both monoclonal antibodies, the secondary antibody was sheep antimouse (NA 931, Amersham Biosciences) used at 1:5,000. littermate mice were born, an expectedly smaller number given the effects of ␤3 deficiency on placental defects and fetal loss (16) . Thirty-two of these mice survived to weaning (62% survival, P Ͻ 0.001 vs. ␤3
Results

Effects of High-Fat Feeding on Survival in
At the age of 6 weeks, mice were started on a Western-type diet containing 0.15% cholesterol and providing 42% calories as fat. Six weeks later, 96% of the ␤3
littermates were alive ( Fig. 1A , P Ͻ 0.001 by Fisher's exact test). Mice started on chow at the age of 6 weeks showed no difference in survival over the ensuing 6 weeks (Fig. 1B) . To confirm these data, the ␤3 mutation was moved into a different model, LDLR-null mice. ␤3 (Fig. 1D) . For both models, death rates with high-fat feeding were the same in males and females. ␤3-null mice maintained without the apoE or LDLR mutation did not die when fed the Western diet (Fig. 1E ) despite the fact that serum cholesterol levels tripled (Fig. 1F) .
Pneumonitis was the likely cause of spontaneous deaths in high-fat-fed ␤3-null animals in both hyperlipidemic models. The lungs of ␤3 Ϫ/Ϫ apoE Ϫ/Ϫ mice surviving high-fat feeding for 6 weeks were essentially normal ( Fig. 2A) . However, isolated small foci of mononuclear cells were present in lung after 6 weeks of high-fat feeding in both ␤3
mice, confirming previous observations of low-grade pulmonary inflammation in the lungs of high-fat-fed apoE-null mice (21) . Autopsies of eight different ␤3
mice found dead with high-fat feeding showed pneumonitis as the cause of death. Low (Fig. 2B ) and higher (Fig. 2D ) magnification views showed alveolar mononuclear cell infiltrates. Stains of lung tissue for pathogens (including Pneumocystis carinii) and cultures from sentinel animals were negative. In addition to macrophages and lymphocytes, alveolar spaces also contained fibrillar proteinaceous material that stained light pink with periodic acid-Schiff but was negative for fibrin (data not shown). ␤3-null mice have a platelet defect, but iron stains of lung tissue were negative (data not shown), suggesting that pulmonary hemorrhage was not the cause of death. These mice are hyperlipidemic (see below), but Sudan black stains were only faintly positive and oil red O stains were negative (data not shown), suggesting that death was not caused by alveolar lipid. (open bars) mice in apoE-null (Left) and LDLR-null (Right) models. Data for equal numbers of males and females are presented together, because there were no sex-specific differences for any variable. ApoE-null mice were studied at baseline and after 3 and 6 weeks of the Western-type diet. LDLR-null animals were studied for 10 weeks on the same diet, because atherosclerosis is less aggressive in this model. In both models, body weight for animals of each ␤3 genotype increased with high-fat feeding (Fig. 3 A and B) , although ␤3 littermates at 6 weeks (P ϭ 0.0293; Fig. 3A) . Cholesterol levels increased with high-fat feeding (Fig. 3 C and D) . There was no effect of ␤3 genotype on cholesterol in apoE-null mice, but levels were Ϸ25% lower at both 6 (P ϭ 0.0002) and 10 (P ϭ 0.0017) weeks in ␤3 (Fig. 3D) . Size-exclusion chromatography of lipoproteins demonstrated the presence of atherogenic particles in the apoE-null model after 6 weeks ( Fig. 4A ) and in the LDLR-null model after 10 weeks (Fig.  4B) . Lipoprotein profiles for Western diet-fed apoE ϩ/ϩ LDLR ϩ/ϩ mice in the presence and absence of ␤3 are shown in Fig. 4C .
The tendency for lower cholesterol levels and anemia (22) in ␤3-deficient mice would be predicted to decrease atherosclerosis. However, ␤3-null mice (Fig. 5 Left) had more atherosclerosis than ␤3 ϩ/ϩ littermates (Fig. 5 Right) in both the apoE-null (Upper) and LDLR-null models (Lower). Lesions were 2.6-fold greater at the arch, 3.3-fold greater at the thoracic aorta, and 5.6-fold greater at the abdominal aorta (all P Ͻ 0.0001) in ␤3 
CD36, CD40L, and CD40 Expression in Lung and Cultured Aortic Smooth
Muscle Cells. ␤3 interacts with several proinflammatory molecules. CD40L binds to ␣IIb␤3 on platelets in a ␤3-dependent fashion (23) . CD36 is associated with ␣IIb␤3 on platelets and cooperates with ␣v␤3 in phagocytosis of apoptotic cells (24, 25) . In normal lungs from high-fat-fed LDLR mice (Fig. 6A) , CD36, CD40L, and CD40 (the receptor for CD40L) expression was increased 5-to 6-fold in (Inset, lane 1) lung. The difference did not correlate with mRNA levels, but CD36 expression is known to be regulated translationally (26) .
To determine whether reconstitution of ␤3 affects expression of these inflammatory markers, we established primary cultures of smooth muscle cells from the aortas of apoE-null mice. ␤3 protein was reconstituted in ␤3-null cells by using a retrovirus expressing the full-length human ␤3 integrin. Its expression was detected by Western blotting in ␤3
smooth muscle cells infected with the ␤3 retrovirus (Fig. 6B, lane 2) but not in the same cells infected with a control retrovirus (Fig. 6B, lane 1) .
Message levels for CD36, CD40L, and CD40 ( (Fig. 6C Center) . However, Fig. 3 . Body weight and serum chemistries in mice. Data are presented for ␤3 ϩ/ϩ (filled bars) and ␤3 Ϫ/Ϫ littermate (open bars) mice in the apoE-null (A, C, E, and G) and LDLR-null (B, D, F, and H) models. Animals were studied at the age of 6 weeks on a chow diet (baseline) and then again 3 and 6 weeks after high-fat feeding for the apoE-null model and 3, 6, and 10 weeks after high-fat feeding for the LDLR-null model. Results are presented as mean Ϯ SEM for decreasing numbers of mice over time due to spontaneous deaths. * , P value in comparison to ␤3 ϩ/ϩ mice at the same time point by unpaired two-tailed t test: A, P ϭ 0.0293; D, P ϭ 0.0002 at 6 weeks and 0.0017 at 10 weeks; H, P ϭ 0.0026. ABCA1 Expression in ␤3-Deficient Mice. Given the potential role of reverse cholesterol transport in atherosclerosis, we measured ABCA1 expression in liver, a tissue with message levels of ABCA1 similar to macrophages in mice (27) . ABCA1 (normalized to GAPDH) message levels were no different in ␤3
(82 Ϯ 21 arbitrary units, n ϭ 3, P ϭ 0.3087) mice.
Discussion
Hyperlipidemia promotes atherosclerosis, as does inflammation, and inflammatory markers might rival atherogenic lipoproteins as predictors of vascular events (28) . The processes linking hyperlipidemia and inflammation are obscure. In this article we show that the absence of the integrin ␤3 enhances the susceptibility of two distinct organs, aorta and lung, to inflammation caused by dietmediated hyperlipidemia. Proatherogenic and proinflammatory mediators known to be induced by hyperlipidemia are elevated in ␤3-deficient mice and suppressed by reconstitution of ␤3. Our results indicate that ␤3-mediated signaling may limit inflammation induced by hypercholesterolemia.
␤3 integrin-deficient mice in two different models of genetic hyperlipidemia, apoE deficiency and LDLR deficiency, have a high frequency of death induced by high-fat feeding (Fig. 1) . A likely contributor to the phenotype is noninfectious pneumonitis, characterized by macrophage and lymphocyte infiltration but not by alveolar lipids or hemorrhage (Fig. 2) . This observation is unexpected but not unprecedented. Dietary cholesterol accelerates pulmonary inflammation in a mouse model of asthma (29) , and lipid levels may modulate several limbs of the inflammatory response (30) (31) (32) . Previous data suggest a role for integrins in the suppression of pulmonary inflammation. Mice with deficiency of the ␤6 integrin have pulmonary and skin inflammation on a chow diet (33) . Inactivation of thrombospondin-1, a major ligand for the ␣v␤3 integrin (absent in the ␤3-null mice of the current study), causes noninfectious pneumonia in chow-fed mice (34) . Granulocyte͞macrophage colony-stimulating factor (GM-CSF) is a powerful inducer of ␣v␤3 expression, and low-fat-fed GM-CSF-null mice have pulmonary inflammation and features of alveolar proteinosis (35, 36) .
In both the apoE-null and LDLR-null models, ␤3-deficient mice surviving Western-type feeding had normal lungs but more aortic atherosclerosis than their ␤3 ϩ/ϩ littermates. In LDLR Ϫ/Ϫ mice, increased atherosclerosis occurred despite decreased cholesterol levels (Figs. 3D and 4B) . The reason for this decrease is unknown. However, thrombospondin-1 binds to the LDLR-related protein (LRP) as well as ␣v␤3 (37), raising the possibility that compensatory induction of LRP in the absence of ␣v␤3 would lower cholesterol levels in LDLR-null mice but not apoE-null mice (lacking the key apolipoprotein required for LRP binding).
Increased vascular disease in the absence of members of the ␤3 integrin family is not inconsistent with previous studies. Femoral arteries in ␤3-null mice are not protected from leukocyte recruitment and intimal hyperplasia after guide-wire injury (38) . Humans with Glanzmann thrombasthenia due to deficiency of ␣IIb␤3 alone or both ␣IIb␤3 and ␣v␤3 develop carotid atherosclerosis (11) . Despite the unquestioned efficacy of short-term i.v. inhibition of ␣IIb␤3, long-term oral inhibition of ␣IIb␤3 curiously increases mortality in humans (39) . These observations prompted the speculation that defects in ␤3 signaling could result in compensatory increases in inflammatory mediators (38, 39) .
Our results validate this prediction by showing that in the absence of ␤3, the inflammatory mediators CD36, CD40L, and CD40 (the CD40L receptor) are increased in lung and in cells derived from the vascular wall (Fig. 6) . We specifically assayed these proteins, because they are known to interact with ␤3. CD36 (40) is expressed on platelets, smooth muscle cells, and monocyte͞macrophages and at numerous other sites (with the exception of large vessel endothelium). Among its many functions, CD36 clears apoptotic cells (in conjunction with ␣v␤3; ref. 25 ) and binds oxidized lipoproteins. CD40L (also known as CD154) and its receptor, CD40 (41) , are expressed on lymphocytes, platelets, and the cells of the vasculature including smooth muscle cells. CD40L is a ligand for ␣IIb␤3, critical for Ig class switching, and stimulates inflammatory cytokine production in nonimmune cells.
CD36 and CD40͞CD40L are proinflammatory in models of lung disease. Blocking CD36 decreases pulmonary inflammation in mice treated with bleomycin (42) . Disrupting the CD40͞CD40L interaction decreases pulmonary inflammation in mice after exposure to ionizing radiation (43) .
CD36 and CD40͞CD40L are proatherogenic. CD36-deficient mice in the apoE-null model are protected from diet-induced atherosclerosis (44) . In both the apoE-null and LDLR-null models, disrupting the CD40͞CD40L interaction decreases the initiation and progression of atherosclerotic lesions (45) (46) (47) (48) . We documented increased CD36 and CD40͞CD40L in smooth muscle cells from ␤3-null mice. Smooth muscle cells contain the greatest mass of ␣v␤3 in the normal vasculature. Arterial smooth muscle cell inflammation promotes intimal proliferation and foam cell formation in the setting of dietary hypercholesterolemia (32) .
Both CD36 and CD40͞CD40L are induced by hypercholesterolemia (49, 50) . Our findings suggest that ␤3 serves to limit inflammation, and that its absence up-regulates expression of inflammatory proteins that are induced further by dietary lipids. CD40 signaling may be particularly important in this process. CD40, a member of the tumor necrosis factor receptor family, initiates a signaling cascade that includes p38 mitogen-activated protein kinase (51) . Active p38 mitogen-activated protein kinase may have many detrimental vascular effects and is known to induce pathways that promote cellular lipid uptake (52) .
␤3 was shown recently to have an unexpected suppressive effect on angiogenesis (53) . Blood vessel sprouting is accelerated in ␤3-null mice perhaps because of increased expression of the vascular endothelial growth factor receptor Flk-1. Flk-1 is proatherogenic in apoE-null mice (54) , providing an additional potential mechanism underlying the enhanced atherosclerosis in ␤3-null animals.
Our observations suggest a previously unrecognized link between dietary hypercholesterolemia and integrin-modulated inflammation and raise the possibility that ␤3 agonists selected to promote the suppressive effects of ␤3 signaling on inflammation could be used to treat vascular disease.
